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I n t r o d u c t i o n 
Lysosomal enzymes r e l e a s e d d u r i n g i n f l a m m a t i o n may enhance the 
i n f l a m m a t o r y response by s p e c i f i c a c t i v a t i o n of humoral systems 
( c l o t t i n g , f i b r i n o l y s i s , complement, k a l l i k r e i n / k i n i n system) 
o r by u n s p e c i f i c d e g r a d a t i o n and o x i d a t i o n o f plasma f a c t o r s 
and t i s s u e p r o t e i n s . R e c e n t l y , the pa t h o b i o c h e m i c a l e f f e c t s of 
enzymes of the a z u r o p h i l i c and s p e c i f i c g r a n u l e s o f polymorpho-
n u c l e a r g r a n u l o c y t e s ( e l a s t a s e , c a t h e p s i n G, collagenase, ca-
t h e p s i n B, lysozyme, myeloperoxidase etc.) were i n v e s t i g a t e d i n 
more d e t a i l ( f o r r e v i e w o f l i t e r a t u r e see ( 1 ) ) . N o r m a l l y , t h e 
p r o t e o l y t i c a c t i o n o f the lysosomal p r o t e i n a s e s i s balanced by 
p r o t e i n a s e i n h i b i t o r s p r e s e n t i n plasma or o t h e r body f l u i d s . 
D uring severe i n f l a m m a t i o n , however, these p r o t e i n a s e s may be 
l i b e r a t e d i n amounts exceeding the n a t u r a l i n h i b i t o r l e v e l s so 
t h a t d e s t r u c t i v e processes can occur e i t h e r l o c a l l y or system-
i c a l l y . Evidence c o u l d be presented t h a t l e u k o c y t i c e l a s t a s e i s 
indeed r e l e a s e d d u r i n g s e p t i c e m i a and o t h e r i n f l a m m a t o r y pro-
cesses ( 1 ) . The c o r r e l a t i o n o b s e r v e d between t h e r e l e a s e o f 
t h i s p r o t e i n a s e and the consumption of plasma f a c t o r s i n d i c a t e s 
t h a t l y s o s o m a l enzymes may s i g n i f i c a n t l y c o n t r i b u t e t o t h e 
consumption of plasma f a c t o r s by u n s p e c i f i c p r o t e o l y s i s . Fur-
t h e r o n , a d m i n i s t r a t i o n of an exogenous i n h i b i t o r of lysosomal 
p r o t e i n a s e s i n an e x p e r i m e n t a l a n i m a l model ( e n d o t o x e m i a ) 
caused a s i g n i f i c a n t r e d u c t i o n o f t h e c o n s u m p t i o n o f plasma 
f a c t o r s ( 2 ) . 
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E g l i n — a p r o t e i n a s e i n h i b i t o r which o r i g i n a l l y has been i s o -
l a t e d from t h e l e e c h Hirudo m e d i c i n a l i s — i s a p o t e n t i n h i b i t o r 
of the g r a n u l o c y t e p r o t e i n a s e s e l a s t a s e and c a t h e p s i n G ( 3 ) . 
With regard t o t h e r o l e o f these p r o t e i n a s e s i n i n f l a m m a t o r y 
s t a t e s l i k e s e p t i c shock and trauma e v a l u a t i o n o f a t h e r a p e u t i c 
approach by p r o t e i n a s e i n h i b i t i o n seemed t o be d e s i r a b l e . Since 
e g l i n i s now a v a i l a b l e i n s u f f i c i e n t q u a n t i t i e s (Fa. Ciba 
Geigy/Basel) by g e n e t i c e n g i n e e r i n g ( 4 ) e x p e r i m e n t a l animal 
s t u d i e s were performed i n o r d e r t o e l u c i d a t e the i n h i b i t o r y 
potency of t h i s i n h i b i t o r i n sepsis and s e p t i c shock. 
Methods 
Septicemia was induced i n p i g s by i . v . i n f u s i o n of E . c o l i f o r 
2 hours ( 5 ) . Three d i f f e r e n t p r e p a r a t i o n s of e g l i n were i n -
t r a v e n o u s l y a d m i n i s t e r e d f o r 4 hours: cloned e g l i n c ( b a t c h I 
or batch I I ) o r e g l i n b ( i s o l a t e d from the l e e c h ) . Animals 
(16.5 - 23 kg) were d i v i d e d i n t o 7 groups (Tab. 1 ) . 
Hematologic, hemodynamic, r e s p i r a t o r y , h i s t o l o g i c a l and bioche-
m i c a l parameters were measured by r o u t i n e methods; e x t r a v a s c u -
l a r lung water (EVLW) was e v a l u a t e d u s i n g the thermo-dye-
technique ( 6 ) . E g l i n l e v e l s i n plasma and u r i n e were e s t i m a t e d 
by r a d i a l i m m u n o d i f f u s i o n a p p l y i n g s p e c i f i c a n t i b o d i e s ( 7 ) . 
Results 
Pharmacokinetic d a t a : E g l i n was e x c r e t e d i n u r i n e t o 75-95 % 
w i t h i n 12 h i n animals w i t h normal kidney f u n c t i o n . Animals 
w i t h r e n a l i n s u f f i c i e n c y due t o s e p t i c e m i a showed a s i g n i f i c a n t 
accumulation of e g l i n i n the c i r c u l a t i o n i n d i c a t i n g the p r e -
v a i l i n g r e n a l e l i m i n a t i o n of t h i s i n h i b i t o r . 
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S u r v i v a l time (Tab. 1 ) : Animals of group I I and I I I d i e d w i t h i n 
7.2 _+ 3.0 h and 5.3 _+ 1.5 h, r e s p e c t i v e l y . One p i g o f each of 
these two groups s u r v i v e d 20 hours. Four animals o f group IV 
s u r v i v e d an e x p e r i m e n t a l p e r i o d o f 30 h d e s p i t e f e v e r due t o 
t r a c e s o f e n d o t o x i n p r e s e n t i n batch I o f t h e c l o n e d e g l i n c. 
The mean s u r v i v a l time i n group V was 19.1 + 6 h. I n group VI 
and V I I e n d o t o x i n - f r e e e g l i n was used and a remarkable p r o l o n -
g a t i o n o f s u r v i v a l time was observed i n s p i t e o f t y p i c a l hema-
t o l o g i c a l , hemodynamic and r e s p i r a t o r y d i s o r d e r s due t o s e p t i -
cemia . 
Group B a c t e r i a dosage 
( E . c o l i c e l l s ) 
E g l i n dosage 
(mg/kg x h) 
S u r v i v a l time 
No n i n 12 ml phys. 
NaCl/h f o r 2 h 
i n 50 ml phys.NaCl/h 
f o r 4 h 
h 
I 10 - - 30 
I I 8 3 x 10 9 - 7.2 + 3.0 
I I I 9 3 x 1 0 1 0 - 5.3 + 1 .5 
IV 5 - 3.85 
( E g l i n c; charge I ) 
3 0 ( 4 x ) ; 6. 5(1x) 
V 5 3 x 1 0 9 3.85 
( E g l i n c; charge I ) 
19.1 + 9.6 
VI 2 3 x 10 9 4.55 
( E g l i n b) 
3 0 ( 1 x ) ; 4. 5(1x) 
V I I 7 3 x 1 0 1 0 3.85 
( E g l i n c; charge I I ) 
30(5x);15. 2(2x) 
Table 1: S u r v i v a l time o f p i g s i n e x p e r i m e n t a l bacteremia as a 
f u n c t i o n of b a c t e r i a ( E . c o l i ) and i n h i b i t o r ( E g l i n ) 
dosages. 
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Lung d i s o r d e r s : A s i g n i f i c a n t i n c r e a s e i n e x t r a v a s c u l a r lung 
water was measured i n u n t r e a t e d s e p t i c a n i m a l s , whereas d u r i n g 
and a f t e r e g l i n - a d m i n i s t r a t i o n o n l y a minor r i s e i n EVLW oc-
cured ( F i g , 1 ) . Moreover, i n c o n t r a s t t o u n t r e a t e d s e p t i c p i g s 
e g l i n - t r e a t e d animals showed o n l y modest m o r p h o l o g i c a l lung 
a l t e r a t i o n s ( i n t e r s t i t i a l edema). 
•= i t 7 • 7 4 3 2 I I I I I » 1 * * ? ? ? 1 ? ? ? ? l ? ? ? 7 7 l 
• -—I , — c • 
t C C t t t C t t t * • L t t t t C t t t 1 J » • - « 
F i g . 1: Mean e x t r a v a s c u l a r lung water l e v e l s (EVLW) i n s e p t i c 
p i g s w i t h o u t (a) and w i t h i n h i b i t o r (b) t r e a t m e n t . 
C l o t t i n g f a c t o r s : I n the e g l i n - t r e a t e d groups I V - V I I f a c t o r 
X I I I and a n t i t h r o m b i n I I I l e v e l s decreased t r a n s i e n t l y ( F i g . 
2b, 3b), whereas i n the u n t r e a t e d bacteremic animals (group I I 
and I I I ) a s i g n i f i c a n t consumption of f a c t o r X I I I ( F i g . 2a) and 








* S 1 7 4 4 2 4 • 1 • I # » » 
Bacteremia * Eglin 
E.cli 3 i i m - Efll. 3.95 t ^ t U 
T-H, I 
TT" 
: S 5 $ 5 S 5 5 5 • 5 • 5 • $ 4 J 
* * " * 
*Ttat (Urn) 
F i g . 2: Mean plasma l e v e l s of f a c t o r X I I I i n s e p t i c p i g s w i t h -
out (a) and w i t h i n h i b i t o r (b) t r e a t m e n t . 
a 
Bacteremia 
E.e.n 31 i m 
Bactereiia - Eglin 
E.coli 3 i i m - Uli» 3J5 wA, U 
F i g . 3: Mean plasma l e v e l s o f a n t i t h r o m b i n I I I i n s e p t i c p i g s 
w i t h o u t (a) and w i t h i n h i b i t o r (b) t r e a t m e n t . 
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Conclusions 
Treatment of e x p e r i m e n t a l s e p t i c e m i a i n pi g s e x c l u s i v e l y by 
e g l i n r e v e a l e d a c o n v i n c i n g p r o t e c t i v e e f f e c t of t h i s p r o t e i n -
ase i n h i b i t o r on lun g t i s s u e and consumption o f plasma p r o t e i n s 
probably due t o i n h i b i t i o n o f u n s p e c i f i c p r o t e o l y s i s . Since, 
however, some severe organ f a i l u r e s (e.g. r e n a l i n s u f f i c i e n c y ) 
due t o septicemia c o u l d not be overcome, a c o m b i n a t i o n o f the 
i n h i b i t o r a d m i n i s t r a t i o n w i t h an approved i n t e n s i v e care t h e r a -
py (e.g. catecholamines, r e s p i r a t o r y t h e r a p y ) i s needed f o r an 
o p t i m a l outcome. 
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